Honeywell Industry Solutions has been signed up by GlaxoSmithKline to implement a software-based system designed to manage the multinational's clinical manufacturing operations.
The POMS CMS enterprise production management system will be used at GSK's R&D facilities in Tonbridge and Stevenage in the UK, and also at the company's product development facility at Upper Providence, Pennsylvania, US.
Honeywell said that GSK had invested $500,000 (€445,000) in the POMS CMS "to ensure consistent deployment of best business practices across the three sites." The system is compliant with the US Food and Drug Administration's 21 CFR Part 11 regulation that sets standards for electronic record keeping.
Dermot Moynihan, senior vice president of chemicals development at GSK, said that the use of POMS CMS "enables us to minimize risk, and eliminate unnecessary delays during our chemical development processes."
POMS CMS is used to manage raw materials, intermediates and consumables during product development and supports several functions, including raw material identification, material receipt and labelling, material status, material issue and return and warehouse management. It also supports reports and queries.
Honeywell said that the system provides complete traceability through all stages of clinical supplies processes, from raw materials to shipment to the investigator and returns.